Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-26T02:22:23.110Z Has data issue: false hasContentIssue false

1 - Epidemiology of Ovarian Cancer

Published online by Cambridge University Press:  11 September 2009

By
Karim Elmasry  and
Simon A. Gayther
Edited by
Rodney Reznek
Karim Elmasry
Affiliation:
Translational Research Labs, Windeyer Institute, University College London, UK.
Simon A. Gayther
Affiliation:
Translational Research Labs, Windeyer Institute, University College London, UK.
Rodney Reznek
Affiliation:
St. Bartholomew's Hospital, London
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Cancer of the Ovary , pp. 1 - 19
Publisher: Cambridge University Press
Print publication year: 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cancer Statistics Registrations. Registrations of cancer diagnosed in 2001, England. London: Office for National Statistics, HMSO. ISSN 0143-4829, ISBN 1 85774 587 6.
Stratton, J. F., Pharoah, P. D. P., Smith, S. K., et al. A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol (1998), 105:493–9.CrossRefGoogle ScholarPubMed
Auranen, A., Pukkala, E., Makinen, J., et al. Cancer incidence in the first-degree relatives of ovarian cancer patients. Br J Cancer (1996), 74:280–4.CrossRefGoogle ScholarPubMed
Easton, D. F., Matthews, F. E., Ford, D., et al. Cancer mortality in relatives of women with ovarian cancer: the OPCS study. Int J Cancer (1996), 65:284–94.3.0.CO;2-W>CrossRefGoogle ScholarPubMed
Schildkraut, J. M. and Thompson, W. D.. Familial ovarian cancer: a population-based case-control study. Am J Epidemiol (1988), 128:456–66.CrossRefGoogle ScholarPubMed
Sutcliffe, S., Pharoah, P. D., Easton, D. F., et al. Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer. Int J Cancer (2000), 87:110–7.3.0.CO;2-6>CrossRefGoogle ScholarPubMed
Lichtenstein, P., Holm, N. V., Verkasalo, P. K., et al. Environmental and heritable factors in the causation of cancer – analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med (2000), 343:78–85.CrossRefGoogle Scholar
Houlston, R. S., Collins, A., Slack, J., et al. Genetic epidemiology of ovarian cancer: segregation analysis. Ann Hum Genet (1991), 55:291–9.CrossRefGoogle ScholarPubMed
Auranen, A. and Iselius, L.. Segregation analysis of epithelial ovarian cancer in Finland. Br J Cancer (1998), 77:1537–41.CrossRefGoogle ScholarPubMed
Miki, Y., Swensen, J., Shattuck-Eidens, D., et al. A strong candidate for the 17 linked breast and ovarian cancer susceptibility geneBRCA1. Science (1994), 266:66–71.CrossRefGoogle ScholarPubMed
Futreal, P. A., Liu, Q., Shattuck-Eidens, D., et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science (1994), 266:120–2.CrossRefGoogle ScholarPubMed
Wooster, R., Bignell, G., Lancaster, J., et al. Identification of the breast cancer susceptibility gene BRCA2. Nature (1995), 378:789–92.CrossRefGoogle ScholarPubMed
Gayther, S. A., Russell, P., Harrington, P., et al. The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes. Am J Hum Genet (1999), 65:1021–9.CrossRefGoogle ScholarPubMed
Matsushima, M., Kobayashi, K., Emi, M., et al. Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: four germline mutations, but no evidence of somatic mutation. Hum Mol Genet (1995), 4:1953–6.CrossRefGoogle ScholarPubMed
Stratton, J. F., Gayther, S. A., Russell, P., et al. Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med (1997), 336:1125–30.CrossRefGoogle ScholarPubMed
Rubin, S. C., Blackwood, M. A., Bandera, C., et al. BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing. Am J Obstet Gynecol (1998), 178:670–7.CrossRefGoogle Scholar
Janezic, S. A., Ziogas, A., Krumroy, L. M., et al. Germline BRCA1 alterations in a population-based series of ovarian cancer cases. Hum Mol Genet (1999), 8:889–97.CrossRefGoogle Scholar
Risch, H. A., McLaughlin, J. R., Cole, D. E., et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet (2001), 68:700–10.CrossRefGoogle Scholar
Ford, D., Easton, D. F., Bishop, D. T., et al. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet (1994), 343:692–5.CrossRefGoogle ScholarPubMed
Whittemore, A. S., Gong, G. and Itnyre, J.. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. Am J Hum Genet (1997), 60:496–504.Google ScholarPubMed
Struewing, J. P., Hartge, P., Wacholder, S., et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med (1997), 336:1401–8.CrossRefGoogle ScholarPubMed
Ford, D., Easton, D. F., Stratton, M., et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1998), 62:676–89.CrossRefGoogle ScholarPubMed
Rubin, S. C., Benjamin, I., Behbakht, K., et al. Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med (1996), 335:1413–6.CrossRefGoogle ScholarPubMed
Boyd, J., Sonoda, Y., Federici, M. G., et al. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA (2000), 283:2260–5.CrossRefGoogle ScholarPubMed
Johannsson, O. T., Ranstam, J., Borg, A., et al. Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. J Clin Oncol (1998), 16:398–404.CrossRefGoogle ScholarPubMed
Pharoah, P. D., Easton, D. F., Stockton, D. L., et al. Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group. Cancer Res (1999), 59:868–71.Google ScholarPubMed
Aarnio, M., Mecklin, J. P., Aaltonen, L. A., et al. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer (1995), 64:430–3.CrossRefGoogle ScholarPubMed
Wheeler, J. M., Bodmer, W. F. and Mortensen, N. J.. DNA mismatch repair genes and colorectal cancer. Gut (2000), 47:148–53.CrossRefGoogle ScholarPubMed
Aarnio, M., Sankila, R., Pukkala, E., et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer (1999), 81:214–18.3.0.CO;2-L>CrossRefGoogle ScholarPubMed
Lowe, S. M., Coughlan, S. J., McKenna, N. J., et al. Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion. Cancer Res (1995), 55:2743–5.Google Scholar
Spurdle, A. B., Webb, P. M., Purdie, D. M., et al. No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancer. Carcinogenesis (2001), 22:717–21.CrossRefGoogle ScholarPubMed
Lancaster, J. M., Berchuck, A., Carney, M. E., et al. Progesterone receptor gene polymorphism and risk for breast and ovarian cancer. Br J Cancer (1998), 78:277.CrossRefGoogle ScholarPubMed
Pearce, C. L., Hirschhorn, J. N., Wu, A. H., et al. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis. J Natl Cancer Inst (2005), 97:51–9.CrossRefGoogle ScholarPubMed
Berchuck, A., Schildkraut, J. M., Wenham, R. M., et al. Progesterone receptor promoter +331A polymorphism is associated with increased risk of endometrioid and clear cell ovarian cancers. Cancer Epidemiol Biomarkers Prev (2004), 13:2141–74.Google ScholarPubMed
Spurdle, A. B., Webb, P. M., Chen, X., et al. Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer. Int J Cancer (2000), 87:637–43.3.0.CO;2-R>CrossRefGoogle ScholarPubMed
Levine, D. A. and Boyd, J.. The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series. Cancer Res (2001), 61:908–11.Google ScholarPubMed
Garner, E. I., Stokes, E. E., Berkowitz, R. S., et al. Polymorphisms of the estrogen metabolizing genes CYP17 and catechol-O-methyltransferase and risk of epithelial ovarian cancer. Cancer Res (2002), 62:3058–62.Google ScholarPubMed
Spurdle, A. B., Chen, X., Abbazadegan, M., et al. CYP17 promotor polymorphism and ovarian cancer risk. Int J Cancer (2000), 86:436–9.3.0.CO;2-A>CrossRefGoogle ScholarPubMed
Runnebaum, I. B., Tong, X. W., Konig, R., et al. p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer. Lancet (1995), 345:994.CrossRefGoogle ScholarPubMed
Lancaster, J. M., Brownlee, H. A., Wiseman, R. W., et al. p53 polymorphism in ovarian and bladder cancer. Lancet (1995), 346:182.CrossRefGoogle ScholarPubMed
Fuller, R. E., Sood, A., Fullenkamp, C., et al. The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis. Cancer Gene Ther (1997), 4:239–45.Google Scholar
Spurdle, A. B., Purdie, D., Chen, X., et al. The prohibitin 3′ untranslated region polymorphism is not associated with risk of ovarian cancer. Cancer Res (2003), 90:145–9.Google Scholar
Lancaster, J. M., Taylor, J. A., Brownlee, H. A., et al. Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol Carcinog (1996), 17:160–2.3.0.CO;2-J>CrossRefGoogle ScholarPubMed
Spurdle, A. B., Purdie, D. M., Webb, P. M., et al. The microsomal epoxide hydrolase Tyr113His polymorphism: association with risk of ovarian cancer. Mol Carcinog (2001), 30:71–8.3.0.CO;2-9>CrossRefGoogle ScholarPubMed
Hengstler, J. G., Kett, A., Arand, M., et al. Glutathione S-transferase T1 and M1 gene defects in ovarian carcinoma. Cancer Lett (1998), 130:43–8.CrossRefGoogle ScholarPubMed
Spurdle, A. B., Webb, P. M., Purdie, D. M., et al. Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype. Carcinogenesis (2001), 22:67–72.CrossRefGoogle ScholarPubMed
Heitzel, J. N., Ding, S., Larson, G. P., et al. The HRAS1 minisatellite locus and risk of ovarian cancer. Cancer Res (2000), 60:259–61.Google Scholar
Cramer, D. W., Hutchison, G. B., Welch, W. R., et al. Determinants of ovarian cancer risk. I. Reproductive experiences and family history. J Natl Cancer Inst (1983), 71:711–6.Google Scholar
Riman, T., Dickman, P. W., Nilsson, S., et al. Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study. Am J Epidemiol (2002), 156:363–73.CrossRefGoogle ScholarPubMed
Whittemore, A. S., Harris, R. and Itnyre, J.. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol (1992), 136:1184–203.CrossRefGoogle ScholarPubMed
Purdie, D., Green, A., Bain, C., et al. Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group. Int J Cancer (1995), 62:678–84.CrossRefGoogle ScholarPubMed
Polychronopoulou, A., Tzonou, A., Hsieh, C. C., et al. Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer. Int J Cancer (1993), 55:402–7.CrossRefGoogle ScholarPubMed
Booth, M., Beral, V. and Smith, P.. Risk factors for ovarian cancer: a case-control study. Br J Cancer (1989), 60:592–8.CrossRefGoogle ScholarPubMed
Hankinson, S. E., Colditz, G. A., Hunter, D. J., et al. A prospective study of reproductive factors and risk of epithelial ovarian cancer. Cancer (1995), 76:284–90.3.0.CO;2-5>CrossRefGoogle ScholarPubMed
Adami, H. O.., Hsieh, C. C., Lambe, M., et al. Parity, age at first childbirth, and risk of ovarian cancer. Lancet (1994), 344:1250–4.CrossRefGoogle ScholarPubMed
Risch, H. A., Marrett, L. D. and Howe, G. R.. Parity, contraception, infertility, and the risk of epithelial ovarian cancer. Am J Epidemiol (1994), 140:585–97.CrossRefGoogle ScholarPubMed
Mosgaard, B. J., Lidegaard, O., Kjaer, S. K., et al. Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. Fertil Steril (1997), 67:1005–12.CrossRefGoogle ScholarPubMed
Gwinn, M. L., Lee, N. C., Rhodes, P. H., et al. Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer. J Clin Epidemiol (1990), 43:559–68.CrossRefGoogle ScholarPubMed
The reduction in risk of ovarian cancer associated with oral-contraceptive use. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. N Engl J Med (1987), 316:650–5.
Rosenberg, L., Palmer, J. R., Zauber, A. G., et al. A case-control study of oral contraceptive use and invasive epithelial ovarian cancer. Am J Epidemiol (1994), 139:654–61.CrossRefGoogle ScholarPubMed
Hankinson, S. E., Colditz, G. A., Hunter, D. J., et al. A quantitative assessment of oral contraceptive use and risk of ovarian cancer. Obstet Gynecol (1992), 80:708–14.Google ScholarPubMed
Stanford, J. L.. Oral contraceptives and neoplasia of the ovary. Contraception (1991), 43:543–56.CrossRefGoogle ScholarPubMed
Franceschi, S., Parazzini, F., Negri, E., et al. Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use. Int J Cancer (1991), 49:61–5.CrossRefGoogle ScholarPubMed
Risch, H. A., Marrett, L. D., Jain, M., et al. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. Am J Epidemiol (1996), 144:363–72.CrossRefGoogle ScholarPubMed
Rosenblatt, K. A., Thomas, D. B. and Noonan, E. A.. High-dose and low-dose combined oral contraceptives: protection against epithelial ovarian cancer and the length of the protective effect. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Eur J Cancer (1992), 28A:1872–6.CrossRefGoogle ScholarPubMed
Liang, A. P., Levenson, A. G., Layde, P. M., et al. Risk of breast, uterine corpus, and ovarian cancer in women receiving medroxyprogesterone injections. JAMA (1983), 249:2909–12.CrossRefGoogle ScholarPubMed
Modan, B., Hartge, P., Hirsh-Yechezkel, G., et al. National Israel Ovarian Cancer Study Group. Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. N Engl J Med (2001), 345:235–40.CrossRefGoogle ScholarPubMed
Narod, S. A., Risch, H., Moslehi, R., et al. Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group. N Engl J Med (1998), 339: 424–8.CrossRefGoogle ScholarPubMed
Whittemore, A. S., Balise, R. R., Pharoah, P. D., et al. Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations. Br J Cancer (2004), 91:1911–5.CrossRefGoogle ScholarPubMed
Mosgaard, B. J., Lidegaard, O., Kjaer, S. K., et al. Ovarian stimulation and borderline ovarian tumors: a case-control study. Fertil Steril (1998), 70:1049–55.CrossRefGoogle ScholarPubMed
Parazzini, F., Negri, E., Vecchia, C., et al. Treatment for infertility and risk of invasive epithelial ovarian cancer. Hum Reprod (1997), 12:2159–61.CrossRefGoogle ScholarPubMed
Dor, J., Lerner-Geva, L., Rabinovici, J., et al. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertil Steril (2002), 77:324–7.CrossRefGoogle Scholar
Doyle, P., Maconochie, N., Beral, V., et al. Cancer incidence following treatment for infertility at a clinic in the UK. Hum Reprod (2002), 17:2209–13.CrossRefGoogle Scholar
Venn, A., Watson, L., Bruinsma, F., et al. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet (1999), 354:1586–90.CrossRefGoogle ScholarPubMed
Lacey, J. V. Jr, Mink, P. J., Lubin, J. H., et al. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA (2002), 288:334–41.CrossRefGoogle ScholarPubMed
Rodriguez, C., Patel, A. V., Calle, E. E., et al. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. JAMA (2001), 285:1460–5.CrossRefGoogle Scholar
Riman, T., Dickman, P. W., Nilsson, S., et al. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. J Natl Cancer Inst (2002), 94: 497–504.CrossRefGoogle ScholarPubMed
Anderson, G. L., Judd, H. L., Kaunitz, A. M., et al. Women's Health Initiative Investigators. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. JAMA (2003), 290:1739–48.CrossRefGoogle ScholarPubMed
Graham, J. and Graham, R.. Ovarian cancer and asbestos. Environ Res (1967), 1:115–28.CrossRefGoogle ScholarPubMed
Venter, P. F. and Iturralde, M.. Migration of a particulate radioactive tracer from the vagina to the peritoneal cavity and ovaries. S Afr Med J (1979), 55:917–9.Google ScholarPubMed
Cramer, D. W., Liberman, R. F., Titus-Ernstoff, L., et al. Genital talc exposure and risk of ovarian cancer. Int J Cancer (1999), 81:351–6.3.0.CO;2-M>CrossRefGoogle ScholarPubMed
Miracle-McMahill, H. L., Calle, E. E., Kosinski, A. S., et al. Tubal ligation and fatal ovarian cancer in a large prospective cohort study. Am J Epidemiol (1997), 145:349–57.CrossRefGoogle Scholar
Green, A., Purdie, D., Bain, C., et al. Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women's Health Study Group. Int J Cancer (1997), 71:948–51.3.0.CO;2-Y>CrossRefGoogle ScholarPubMed
Kreiger, N., Sloan, M., Cotterchio, M., et al. Surgical procedures associated with risk of ovarian cancer. Int J Epidemiol (1997), 26:710–15.CrossRefGoogle ScholarPubMed
Hankinson, S. E., Hunter, D. J., Colditz, G. A., et al. Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA (1993), 270:2813–18.CrossRefGoogle ScholarPubMed
Ogawa, S., Kaku, T., Amada, S., et al. Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study. Gynecol Oncol (2000), 77:298–304.CrossRefGoogle ScholarPubMed
Takahashi, K., Kurioka, H., Irikoma, M., et al. Benign or malignant ovarian neoplasms and ovarian endometriomas. J Am Assoc Gynecol Laparosc (2001), 8:278–84.CrossRefGoogle ScholarPubMed
Schildkraut, J. M., Schwingl, P. J., Bastos, E., et al. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol (1996), 88:554–9.CrossRefGoogle ScholarPubMed
Balen, A.. Polycystic ovary syndrome and cancer. Hum Reprod Update (2001), 7:522–5.CrossRefGoogle ScholarPubMed
Risch, H. A. and Howe, G. R.. Pelvic inflammatory disease and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (1995), 4:447–51.Google ScholarPubMed
Parazzini, F., Vecchia, C., Negri, E., et al. Pelvic inflammatory disease and risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev (1996), 5:667–9.Google ScholarPubMed
Ness, R. B., Grisso, J. A., Cottreau, C., et al. Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. Epidemiology (2000), 11:111–17.CrossRefGoogle ScholarPubMed
Hisada, M., Berg, B. J., Strickler, H. D., et al. Prospective study of antibody to human papilloma virus type 16 and risk of cervical, endometrial, and ovarian cancers (United States). Cancer Causes Control (2001), 12:335–41.CrossRefGoogle Scholar
Risch, H. A., Jain, M., Marrett, L. D., et al. Dietary lactose intake, lactose intolerance, and the risk of epithelial ovarian cancer in southern Ontario (Canada). Cancer Causes Control (1994), 5:540–8.CrossRefGoogle Scholar
Vecchia, C., Decarli, A., Negri, E., et al. Dietary factors and the risk of epithelial ovarian cancer. J Natl Cancer Inst (1987), 79:663–9.
Kushi, L. H., Mink, P. J., Folsom, A. R., et al. Prospective study of diet and ovarian cancer. Am J Epidemiol (1999), 149:21–31.CrossRefGoogle ScholarPubMed
Fairfield, K. M., Hankinson, S. E., Rosner, B. A., et al. Risk of ovarian carcinoma and consumption of vitamins A, C, and E and specific carotenoids: a prospective analysis. Cancer (2001), 92:2318–26.3.0.CO;2-7>CrossRefGoogle Scholar
Purdie, D. M., Bain, C. J., Webb, P. M., et al. Body size and ovarian cancer: case-control study and systematic review (Australia). Cancer Causes Control (2001), 12:855–63.CrossRefGoogle Scholar
Kuper, H. D., Cramer, W. and Titus-Ernstoff, L.. Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status?Cancer Causes Control (2002), 13:455–63.CrossRefGoogle ScholarPubMed
Lubin, F., Chetrit, A., Freedman, L. S., et al. Body mass index at age 18 years and during adult life and ovarian cancer risk. Am J Epidemiol (2003), 157:113–20.CrossRefGoogle ScholarPubMed
Lukanova, A., Toniolo, P., Lundin, E., et al. Body mass index in relation to ovarian cancer: a multi-centre nested case-control study. Int J Cancer (2002), 99:603–8.CrossRefGoogle ScholarPubMed
Engeland, A., Tretli, S. and Bjorge, T.. Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst (2003), 95:1244–8.CrossRefGoogle ScholarPubMed
Fairfield, K. M., Willett, W. C., Rosner, B. A., et al. Obesity, weight gain, and ovarian cancer. Obstet Gynecol (2002), 100:288–96.Google ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Epidemiology of Ovarian Cancer
    • By Karim Elmasry, Translational Research Labs, Windeyer Institute, University College London, UK., Simon A. Gayther, Translational Research Labs, Windeyer Institute, University College London, UK.
  • Edited by Rodney Reznek
  • Book: Cancer of the Ovary
  • Online publication: 11 September 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545887.003
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Epidemiology of Ovarian Cancer
    • By Karim Elmasry, Translational Research Labs, Windeyer Institute, University College London, UK., Simon A. Gayther, Translational Research Labs, Windeyer Institute, University College London, UK.
  • Edited by Rodney Reznek
  • Book: Cancer of the Ovary
  • Online publication: 11 September 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545887.003
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Epidemiology of Ovarian Cancer
    • By Karim Elmasry, Translational Research Labs, Windeyer Institute, University College London, UK., Simon A. Gayther, Translational Research Labs, Windeyer Institute, University College London, UK.
  • Edited by Rodney Reznek
  • Book: Cancer of the Ovary
  • Online publication: 11 September 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545887.003
Available formats
×